Christopher J. Reading
Chief Executive Officer at U.S. Physical Therapy Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: U.S. Physical Therapy Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
U.S. Physical Therapy Inc. May 19, 202698.2%
-
U.S. Physical Therapy Inc. May 20, 202597.1%
-
U.S. Physical Therapy Inc. May 21, 202492.2%
-
U.S. Physical Therapy Inc. May 16, 202398.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | U.S. Physical Therapy Inc. | Grant or award | +25,000 | — | — |
| Sep 4, 2025 | U.S. Physical Therapy Inc. | Open-market sale | −2,000 | $83.53 | $167,060 |
| Feb 24, 2025 | U.S. Physical Therapy Inc. | Grant or award | +20,250 | — | — |
| May 30, 2024 | U.S. Physical Therapy Inc. | Open-market sale | −2,900 | $100.26 | $290,754 |
| May 29, 2024 | U.S. Physical Therapy Inc. | Open-market sale | −1,000 | $100.13 | $100,130 |
| May 28, 2024 | U.S. Physical Therapy Inc. | Open-market sale | −1,100 | $102.13 | $112,343 |
| Feb 26, 2024 | U.S. Physical Therapy Inc. | Grant or award | +16,200 | — | — |
| Feb 20, 2023 | U.S. Physical Therapy Inc. | Grant or award | +10,000 | — | — |
Questions about Christopher J. Reading
What boards is Christopher J. Reading on?
Christopher J. Reading sits on the board of U.S. Physical Therapy Inc.
What company is Christopher J. Reading the CEO of?
Christopher J. Reading is Chief Executive Officer of U.S. Physical Therapy Inc.
How long has Christopher J. Reading served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.